Showing results (1221-1230 of 1,369) with videos related to
Sort By:
Pageof 137
Biomedical Optics Express|March 4, 2021
Lightsheet-based flow cytometer for whole blood with the ability for the magnetic retrieval of objects from the blood flowRoman A Verkhovskii, Anastasiia A Kozlova, Olga A Sindeeva, et al.Peerj|May 12, 2021
A DNA barcode library for the butterflies of North AmericaJacopo D'Ercole, Vlad Dincă, Paul A Opler, et al.Genomics|February 7, 2002
Evolution of the regulators of G-protein signaling multigene family in mouse and humanDavid A Sierra, Debra J Gilbert, Deborah Householder, et al.European Journal of Medicinal Chemistry|January 2, 2018
Synthesis and biological evaluation of new water-soluble photoactive chlorin conjugate for targeted deliveryVasilii F Otvagin, Alexander V Nyuchev, Natalia S Kuzmina, et al.Bioorganic Chemistry|April 5, 2019
Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantaneDmitry A Vasilenko, Evgenia V Dueva, Liubov I Kozlovskaya, et al.Natural Product Communications|November 27, 2013
Pulchranins B and C, new acyclic guanidine alkaloids from the Far-Eastern marine sponge Monanchora pulchraTatyana N Makarieva, Ekaterina K Ogurtsova, Yuliya V Korolkova, et al.Kardiologiia|April 16, 2023
[Efficacy and Safety of Nonfluoroscopic Approach During Catheter Ablation of Ventricular Tachycardias]E G Huseynli, O V Sapelnikov, V A Amanatova, et al.International Journal of Molecular Sciences|July 14, 2023
3-[N,N-Bis(sulfonyl)amino]isoxazolines with Spiro-Annulated or 1,2-Annulated Cyclooctane Rings Inhibit Reproduction of Tick-Borne Encephalitis, Yellow Fever, and West Nile VirusesKseniya N Sedenkova, Artem S Sazonov, Dmitry A Vasilenko, et al.Annals of Neurology|May 4, 2010
Novel peptide from spider venom inhibits P2X3 receptors and inflammatory painEugene V Grishin, Ganna A Savchenko, Alexander A Vassilevski, et al.Journal of Cardiovascular Pharmacology|October 2, 2024
Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa studyAntonio Abbate, Benjamin Van Tassell, Vlad Bogin, et al.Pageof 137